Novo Nordisk's CagriSema trial deals blow in obesity drug battle with Eli Lilly US$ 21.95 Min. order: 1 piece ★★★★★ 4.3 (213 reviews) Sold : Login>>
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity US$ 20.11 Min. order: 1 piece ★★★★★ 4.1 (289 reviews) Sold : Login>>
VisualAbstract: Cagrilintide-Semaglutide is Effective for Weight Loss in Adults with Overweight or Obesity and Type 2 Diabetes US$ 25.71 Min. order: 1 piece ★★★★★ 4.1 (155 reviews) Sold : Login>>
Novo Nordisk shares higher on positive Phase 3 trial results for obesity drug Cagrilintide US$ 29.44 Min. order: 1 piece ★★★★★ 4.8 (21 reviews) Sold : Login>>